452
Views
3
CrossRef citations to date
0
Altmetric
Clinical Studies

Cystatin C and Creatinine as Markers for Radiocontrast-Induced Nephropathy in Patients Treated with N-Acetylcysteine

, , &
Pages 85-90 | Received 16 Jul 2009, Accepted 24 Sep 2009, Published online: 01 Feb 2010

REFERENCES

  • Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: A cohort analysis. JAMA 1996;275: 1489–1494.
  • Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349: 1333–1340.
  • Krämer BK, Kammerl M, Schweda F, Schreiber M. A primer in radiocontrast-induced nephropathy. Nephrol Dial Transplant. 1999;14:2830–2834.
  • Tepel M, Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180–184.
  • Boccalandro F, Amhad M, Smalling RW, Sdringola S. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Catheter Cardiovasc Interv. 2003;58:336–341.
  • Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol. 2002;40:298–303.
  • Birck R, Krzossok S, Markowetz F, Schnülle P, van der Woude F, Braun C. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet. 2003;362:598–603.
  • Johnson D. The CARI guidelines. Evaluation of renal function. Use of serum creatinine concentration to assess level of kidney function. Nephrology. 2005;10 (Suppl. 4):133–139.
  • Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin La Sci. 2004;41:467–550.
  • Le Bricon T, Thervet E, Froissart M, Benlakehal M, Bousquet B, Legendre C, Erlich D. Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate three months after kidney transplantation. Clin Chem. 2000;46:1206–1207.
  • Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A. Cystatin C as a marker of GFR—history, indications, and future research. Clin Biochem. 2005;38:1–8.
  • Xu H, Lu Y, Teng D, Wang J, Wang L, Li Y. Assessment of glomerular filtration rate in renal transplant patients using serum cystatin C. Transplant Proc. 2006;38:2006–2008.
  • Mussap M, Dalla Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int. 2002;61:1453–1461.
  • Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, Vera M, Piera C, Darnell A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impaiment. Am J Kidney Dis. 2000;36:29–34.
  • Filler G, Priem F, Lepage N, Sinha P, Vollmer I, Clark H, Keely E, Matzinger M, Akbari A, Althaus H, Jung K. Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem. 2002;48:729–736.
  • Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, Lupi I, Pellegrini G, Bartalena L, Bogazzi F, Martino E. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest. 2005; 28:346–349.
  • Babay Z, Al-Wakeel J, Adda M, Mittwalli A, Tarif N, Hammad D, Ali N, Al-Askar A, Chaudhary AR. Serum cystatin C in pregnant women: Reference values, reliable and superior diagnostic accuracy. Clin Exp Obstet Gynecol. 2005;32:175–179.
  • Bökenkamp A, Wijk JAE, Lentze MJ, Stoffel-Wagner B. Effect of corticosteroid therapy on serum cystatin C and ß2-microglobulin concentrations. Clin Chem. 2002;48: 1123–1126.
  • Aruoma O, Hallowell B, Hoey B, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593–597.
  • Shan Z, Tan D, Satriano J, Silbiger S, Schlöndorff D. Intracellular glutathione influences collagen generation by mesangial cells. Kidney Int. 1994;46:388–395.
  • Hoffmann U, Fischereder M, Krüger B, Drobnik W, Krämer BK. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol. 2004;15:407–410.
  • Rickli H, Benou K, Ammann P, Fehr T, Brunner-La Rocca HP, Petridis H, Riesen W, Wuthrich RP. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol. 2004;62:241–242.
  • Adolph E, Holdt-Lehmann B, Chatterjee T, Paschka S, Prott A, Schneider H, Koerber T, Ince H, Steiner M, Schuff-Werner P, Nienaber CA. Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): A randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Coron Artery Dis. 2008;19(6):413–419.
  • Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Sonel AF, Fine MJ, Palevsky PM. Prevention, incidence, and outcomes of contrast-induced acute kidney injury. Arch Intern Med. 2008;168(12):1325–1332.
  • Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol. 2008;3(1):273–280.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.